Inhibition of yeast ribonucleotide reductase by Sml1 depends on the allosteric state of the enzyme

  • Tessianna A. Misko
  • , Sanath R. Wijerathna
  • , Tomas Radivoyevitch
  • , Anthony J Berdis
  • , Md. Faiz Ahmad
  • , Michael E. Harris
  • , Chris G. Dealwis

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Sml1 is an intrinsically disordered protein inhibitor of Saccharomyces cerevisiae ribonucleotide reductase (ScRR1), but its inhibition mechanism is poorly understood. RR reduces ribonucleoside diphosphates to their deoxy forms, and balances the nucleotide pool. Multiple turnover kinetics show that Sml1 inhibition of dGTP/ADP- and ATP/CDP-bound ScRR follows a mixed inhibition mechanism. However, Sml1 cooperatively binds to the ES complex in the dGTP/ADP form, whereas with ATP/CDP, Sml1 binds weakly and noncooperatively. Gel filtration and mutagenesis studies indicate that Sml1 does not alter the oligomerization equilibrium and the CXXC motif is not involved in the inhibition. The data suggest that Sml1 is an allosteric inhibitor.
Original languageEnglish
Pages (from-to)1704-1712
Number of pages9
JournalFEBS Letters
Volume590
Issue number12
DOIs
StatePublished - Jun 1 2016

Keywords

  • enzyme kinetics
  • intrinsically disordered protein
  • mixed inhibition
  • nucleotides
  • oligomerization

Cite this